CTOs on the Move

Neoleukin

www.neoleukin.com

 
Neoleukin Therapeutics emerged from the University of Washington Institute for Protein Design in January of 2019. We are creating next generation immunotherapies using breakthrough de novo protein design technology. We use natural protein complexes as inspiration to develop custom designed proteins with superior pharmaceutical properties.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.neoleukin.com
  • 188 East Blaine Suite 450
    Seattle, WA USA 98102
  • Phone: 855.226.6447

Executives

Name Title Contact Details

Similar Companies

Sol Global investments

SOL (CSE:SOL) is an international cannabis company with a focus on legal U.S. states. Its strategic investments and partnerships across cultivation, distribution and retail complement the company`s R&D program with the University of Miami.

Custom Biogenic Systems

Custom Biogenic Systems is a Romeo, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pegasus Laboratories Inc

Pegasus Laboratories Inc is a Pensacola, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Arresto BioSciences

Arresto BioSciences is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.